Sports
Follow along with Times staffers for live Super Bowl reaction and analysis
Topics

Stem Cell Research

California's stem cell agency charts course for next five years

California's stem cell agency charts course for next five years

California's stem cell agency has adopted a sweeping new plan to chart its course for the next five years and possibly beyond.

The plan approved by the California Institute for Regenerative Medicine's board aims to make the best possible use of the approximately $900 million left from the $3 billion state voters earmarked for the institute, said Randy Mills, the institute's president. The goal is to get as many important treatments to patients in that time, or at least get them well on the way.

The plan completes a major reorganization announced by Mills in September. It gives more consideration for projects that seek to translate basic lab research into clinical trials for...

Loading
82°